Dr P Vijay Anand Reddy

Radiation Oncologist

30+ Years Experience

MBBS MD (Radiotherapy) DNB (Radiotherapy) Medical Oncology (ESMO) FUICC FNDM FUICC

Jubilee Hills, Hyderabad

English, Hindi, Telugu, Hindi, Telugu

MON-SAT

Overview

Dr Vijay Anand Reddy P: Experienced Radiation Specialist Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar, Hyderabad.

Dr Vijay Anand Reddy P a highly regarded Radiation Specialist Oncologist with 30+ years of experience, practices at Apollo Hospitals Jubilee Hills in Hyderabad. Dr Vijay Anand Reddy P has completed his MBBS, MD (Radiotherapy), DNB (Radiotherapy), Med. Onco., FUICC, FNDM, FUICC. He offers a wide range of services to address various conditions: Brain Tumour, vulvar-cancer, Osteosarcoma Treatment, Salivary Gland Tumours, Mouth cancer, Merkel cell carcinoma, Glioma, Meningioma, Esophageal Cancer, Wilms Tumour, Retinoblastoma, vasc, Breast Lumps, Nonmelanoma skin cancer, Osteosarcoma.

If you’re seeking Radiation Specialist Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar areas of Hyderabad, Dr. Vijay Anand Reddy P is the right choice for expert care and treatment of your Radiation Oncology needs. Book an appointment today and experience top-notch medical care.

Registration No: 10495

Education

As Director of Apollo Cancer Institute Hyderabad, Dr Reddy has been instrumental in the establishment and growth of the institute and its latest entitlement to ‘ Center of Excellence for Cancer’ .

Full Member of American Society of Clinical Oncology (ASCO)Full Member of American Society for Radiation Oncology (ASTRO)Permanent Member of European Society of Medical Oncology (ESMO)Permanent Member of &ldquo Union for International Cancer Control&rdquo , UICC, GenevaPresident of Association of Radiation Oncologists of India (AROI)President of Association of Radiation Oncologists of India (AROI), Telangana ChapterPresident of Association of Radiation Oncologists of India (AROI), AP Chapter (Past)Member of Indian College of Radiation Oncology (ICRO)Chairman, Indian College of Radiation Oncology (ICRO), INDIAMember of Indian Society of Oncology (ISO)Member of Civil Assistant Surgeon& s Association, Andhra PradeshMember of Indian Medical Association (IMA)Member of Indian Co-operative Oncology Network (ICON)Member of Indian Brachytherapy Society (IBS)

Full Member of American Society of Clinical Oncology (ASCO)
Full Member of American Society for Radiation Oncology (ASTRO)
Permanent Member of European Society of Medical Oncology (ESMO)
Permanent Member of Union for International Cancer Control, UICC, Geneva President of Association of Radiation Oncologists of India (AROI)
President of Association of Radiation Oncologists of India (AROI),
Telangana Chapter President of Association of Radiation Oncologists of India (AROI),
AP Chapter (Past)Member of Indian College of Radiation Oncology (ICRO)Chairman, Indian College of Radiation Oncology (ICRO),
INDIA Member of Indian Society of Oncology (ISO)Member of Civil Assistant Surgeon& s Association, Andhra Pradesh Member of Indian Medical Association (IMA)
Member of Indian Co-operative Oncology Network (ICON)Member of Indian Brachytherapy Society (IBS)

Experience

Director & Sr. Consultant, Apollo Cancer Hospital, Hyderabad, since April 2002.
Consultant Ocular Oncologist, L. V. Prasad Eye Institute since 1998.
Stereotactic Radiosurgery Fellowship at Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany, March 2010.
Ocular Oncology Fellowship at Children’s Hospital of Philadelphia, USA & Will’s Eye Hospital, Philadelphia, USA, May-June 2003.
Head & Neck Oncology Fellowship: Peter MacCallum Cancer Institute, Melbourne, Australia, July-August 1998.
Head & Neck Brachytherapy Observership: The Memorial Sloan Kettering Cancer Centre, New York, June 1995.
Nargis Dutt Memorial Cancer Foundation Fellowship: The New York Hospital, Medical Centre of Queens, New York, May-July 1995.
Clinical Observership: Christie Hospital, Manchester, United Kingdom, Sept 1992.
Clinical Oncology Fellowship: The Meyerstein Institute of Oncology, The Middle Sex Hospital, London, July-Sept 1992.
Associate Professor of Radiation Oncology, Kakatiya Medical College, Warangal, April 1999-April 2001.
Assistant Professor, MNJ Institute of Oncology, Red Hills, Hyderabad, April 1992-1999.
Clinical Oncology Fellowship: Adyar Cancer Institute, Chennai, Jan 1990.
Medical Oncology Fellowship: Nizam Institute of Medical Sciences, Hyderabad, Sept 1990.
Radiation Oncology Fellowship: Tata Memorial Hospital, Mumbai, March-August 1990.
Elected as the Chairman ICRO (Indian College of Radiation Oncology), a prestigious body, December 2012.

Doctor Awards

Dr. Vijay Anand Reddy has been awarded as &ldquo
The Legend in the Field of Oncology&rdquo at the Times Healthcare Achievers Awards function at HICC, Hyderabad on 28th Feb& 2017.
Best Scientific Paper Award 2015&rdquo for Prospective study of Neurocognitive function, performance status, quality of life and local control in patients with 1-3 newly diagnosed brain metastases treated with stereotactic radio surgery alone Awarded by AROICON 2015, Lucknow, INDIA
Best Scientific Paper Award 2014&rdquo for A Prospective Observational Feasibility Study of Hypofractionated Radiotherapy for Clinically localized Carcinoma Prostate Awarded by AROICON 2014, Imphal, INDIA
American Academy of Ophthalmology Achievement Award Best Scientific Paper Award 2009&rdquo for Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors Awarded by AROICON 2009, Hyderabad, INDIA&ldquo
Best Scientific Poster Award 2009&rdquo for Histopathology of Retinoblastoma after primary Chemotherapy Awarded by AROICON 2009, Hyderabad,
INDIA&ldquo BEST POSTER&rdquo AWARD 2008 Awarded by American Academy of Ophthalmology at Atlanta, GA, USA&ldquo
YOUNG INVESTIGATORS AWARD&rdquo 2001 Awarded at New Delhi by Eli Lilly & Company, USA&ldquo INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1998 by UICC, Geneva, Switzerland&ldquo
YOUNG SCIENTIST AWARD&rdquo 1996 Awarded by Indo-American Cancer Congress, New York, USA&ldquo
BEST SCIENTIFIC PAPER AWARD&rdquo 1996 at XVIII National Conference of Assoc.
Oncologists of India&rdquo at Aurangabad&ldquo
NARGIS DUTT MEMORIAL FOUNDATION AWARD&rdquo 1995 Awarded by Nargis Dutt Memorial Foundation, Flushing, New York&ldquo
INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1992 by UICC, Geneva, Switzerland.
Presentations of Cancer: Invited as a Panelist for the &ldquo Gynecological Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017.
Invited as a Panelist for the &ldquo Lung Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017. Invited as a Chairperson for the Panel discussion on &ldquo Opening the Lid for Bevacizumab in Gynecological Malignancies&rdquo CME Organized by Intas Oncology, Hyderabad on July 12, 2017.
Invited as a Chairperson for the Session on &ldquo Expert talk in NSCLC&rdquo CME Organized by Novartis Oncology, Hyderabad on June 13, 2017. &ldquo Radiotherapy in Retinoblastoma&rdquo at Retinoblastoma Networking Workshop, LVPEI,
Hyderabad from June 10-12, 2017. &ldquo Breast&rdquo at Best of ASTRO 2017,
Vizag on May 13-14, 2017. &ldquo Bilateral Breast using TomoTherapy&rdquo at Accuray User& s Meeting,
Bangalore on April 22-23, 2017. &ldquo Re-irradiation When and how to?&rdquo Session on &ldquo
Novel therapies Part III Molecular Neuro-Oncology Resistance and re-treatment&rdquo at 9th annual Conference of Indian Society of Neuro-Oncology (ISNOCON 2017), Bangalore from January 10-12, 2017. &ldquo Crossfire: Surgery vs Radiotherapy for high risk early Prostate Cancer&rdquo at First Prostate Cancer Symposium PRiSM 2016 organized by Dr. Reddy& s Laboratories Ltd. ,
Hyderabad from December 17-18, 2016. &ldquo Optimal treatment for oligo brain metastasis: Role of SRS&rdquo Session on &ldquo CNS Debate (Debator – 1 in favour of SRS)&rdquo at 39th AROICON 2016,
Bhubaneshwar from November 24-27, 2016. &ldquo Plaque Brachytherapy for Ocular Tumor&rdquo Session on &ldquo Paediatrics Oncology&rdquo at 39th AROICON 2016, Bhubaneshwar from November 24-27, 2016. &ldquo Ocular Brachytherapy&rdquo at AROICON – 2016, TN-PY Chapter,
Chennai on October 15-16, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Recent Advances in Surgical Procedures,
Dubai UAE on September 30, 2016. &ldquo Organ Preservation Protocols our experience&rdquo at FHNO South-East Zonal CME on Ca. Larynx, Organized by Apollo Cancer Institute in association with AOI Hyderabad & Telangana State Branches, Hyderabad on September 3, 2016. &ldquo Brachytherapy in Ophthalmic
Tumors&rdquo at 6th Annual Conference of IBSCON 2016, Hyatt Regency, Chennai on August 27-28, 2016. &ldquo Radiotherapy in Elderly Breast Cancer&rdquo Session on &ldquo Breast Cancer in Elderly: Coming of Age&rdquo at Navigating Clinical Conundrums in Breast Cancer, Mumbai on August 20-21, 2016.
&ldquo Overall Scenario of Cancer in India & Prevention & Cure&rdquo Session on &ldquo Cancer Prevention & A Healthy Lifestyle&rdquo at CII Young Indians, Hyderabad on July 28, 2016.
Invited as a Perspective for &ldquo Hard Talk – Perspective in adopting new data&rdquo Session on &ldquo Irradiating the axilla- Why exchange one toxicity for another especially when prognostication is at stake?&rdquo at Controversies in Clinical Oncology, TMH,
Kolkata from July 22-24, 2016. &ldquo New Technology Does it have an impact in the management of Gynaec Cancers Cost vs benefit&rdquo at CME on &ldquo Oncology and Robotics in Gynecology&rdquo , organized by OGSH in association with Apollo Hospitals, Hyderabad on July 16, 2016.
Invited as a Panelist for the Panel discussion on &ldquo Case Based Discussion in Rare Solid Tumors&rdquo at 3rd Mid Term National Conference of Pediatric Hematology Oncology, Hyderabad on July 9-10, 2016.
&ldquo Role of Radiation Oncologist in the Management of Ophthalmic Tumors&rdquo , at EYE CANcer 2016, LVPEI, Hyderabad on July 9, 2016.
Moderator for the Panel Discussion on &ldquo Lung Cancer Non-small Cell / Small Cell / Other&rdquo at Best of ASCO 2016, HICC, Hyderabad on July 1-3, 2016.
Moderator for the Session on &ldquo Each Expert Group Propose Recommendations&rdquo at CME on &ldquo Consensus Recommendations of Expert Group for Management of Advanced Cervical Cancer in India&rdquo , organized by Roche Oncology, Hyderabad on June 18, 2016. &ldquo Cancer Management A Paradigm Shift&rdquo , CME Program on Post Thrombotic Syndrome and Varicose Vein Ulcer Management organized by Apollo Hospitals, Hyderabad in association with IMA, East at Hyderabad on April 24, 2016.
Moderator for the Panel Discussion &ldquo Decision Making for Adjuvant Radiation&rdquo Session on &ldquo Breast Cancer 1: Early Breast Cancer&rdquo at 12th International Conference of Asian Clinical Oncology Society (ACOS), New Delhi from April 8-10, 2016.
Invited as a Chairperson for &ldquo Direction of Current Neuro-oncology Research&rdquo at ISNOCON 2016, Hyderabad from April 1-3, 2016.
Invited as a Panelist for the Head and Neck Cancer& Session on &ldquo Therapeutic Decision Making in Borderline and locally advanced HNSCC&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016.
Invited as a Panelist for the Lunch Symposium on &ldquo Challenges in delivery of chemoradiation in Lung Cancer&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016. &ldquo Did the higher accuracy in treatment delivery translate into noticeable Clinical Improvements?&rdquo at AROI West Bengal Annual State Conference,
Kolkata on February 20-21, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Indian Medical Association (IMA) CME, Hyderabad on February 13, 2016. Invited as a Panelist for the Panel Discussion on &ldquo Nanotechnology based Paclitaxel in Clinical Practice&rdquo at SUN Oncology BEVETEX Symposium, Hyderabad on January 2, 2016.

Research

Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-year Retrospective Study
Translational Vision Science & Technology, June 2017, Vol. 6 No. 3, Article 19, Pg. 1-9.
Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies using Whole Body Nuclear Scintigraphy and SPECT-CT
The American Society of Ophthalmic Plastic and Reconstructive Surgery, 2014, Vol. XX No. XX, Pg. 1-4.
Ophthalmologic Pathology: SY20-2 What is your Diagnosis?
Royal College of Pathologists of Australia, Taylor & Francis, October 2014, Vol. 46 (2), Pg. S30.
Orbital Alveolar Soft-Part Sarcoma: Clinico-pathological Profiles, Management, and Outcomes
Journal of Cancer Research and Therapeutics, April-June 2014, Vol. 10 Issue 2, Pg. 294-298.
Management and Outcome of Retinoblastoma with Vitreous Seeds
American Academy of Ophthalmology, Feb 2014, Vol. 121 (2), Pg. 517-524.
Lacrimal Surgery: Glorious Past, Exciting Present Era, and the Audacity of Hope for a Brilliant Future
Saudi Journal of Ophthalmology, 2014, Vol. 28, Pg. 1-2.
Distant Metastatic Retinoblastoma Without Central Nervous System Involvement
Indian Journal of Ophthalmology, July 2013, Vol. 61(7), Pg. 357-359.
Primary Intraocular Malignant Extrarenal Rhabdoid Tumor: A Clinicopathological Correlation
Journal of Pediatric Ophthalmology and Strabismus, April 2013, Vol. 50, Pg. e18-20.
Adenoid Cystic Carcinoma of the Lacrimal Gland: Role of Nuclear Survivin (BIRC5) as a Prognostic Marker
Histopathology, May 2013, Vol. 62(6), Pg. 840-846.
Optic Nerve Meningeal Hemangiopericytoma: A Clinicopathological Case Report
Survey of Ophthalmology, January 2013, PubMed ID 23294915.
Radiation Oncology in the 21st Century: Changing the Paradigms
Apollo Medicine, June 2012, Vol. 9 No. 2, Pg. 115-125.
Orbital Plasmablastic Lymphoma: A Clinico-Pathological Correlation of a Rare Disease and Review of Literature
Clinical Ophthalmology (Auckland, N.Z.), 2012, Pg. 2049-2057.
Evaluation of HER-2/neu Status in Breast Cancer Specimens using Immunohistochemistry (IHC) & Fluorescence in-situ Hybridization (FISH) Assay
Indian Journal of Medical Research, March 2012, Pg. 312-317.
Establishing Human Lacrimal Gland Cultures with Secretory Function
PLoS One, 2012, Vol. 7(1), e29458.
High Dose Rate Interstitial Brachytherapy in Carcinoma Eyelid: Can it be a Primary Treatment Modality?
Journal of Cancer Research and Therapeutics, Oct-Dec 2011, Vol. 7(4), Pg. 498-499.
First Indian Experience with Shaped Beam Radiosurgery of Cranial and Spinal Lesions on Novalis-Tx Linear Accelerator with ExacTrac 6D Robotic Couch
10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011, Pg. 1166.
Set-up Accuracy with Frameless Radiosurgery of Intracranial Lesions using ExacTrac 6-D Robotic Couch on Novalis-Tx Linear Accelerator
10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011, Pg. 1147.
Comparison of Intensity Modulated Stereotactic Radiosurgery with Conventional Stereotactic Conformal Beam Radiosurgery in Vestibular Schwannomas
10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011, Pg. 1003.
The New Radiation Technology and Techniques: Does it Matter in Gynec Cancer?
Annals of IMA Academy of Medical Specialities, 2011, Pg. 49-53.
Evaluation of Human Lacrimal Gland Cultures for Secretory Function and Putative Stem Cells
Indian Eye Research Group (IEGR), 2011, Pg. 84.
Orbital Retinoblastoma: Where Do We Go from Here?
Journal of Cancer Research and Therapeutics, May 2011, Vol. 7(1), Pg. 11-14.
Cultivation and Characterization of Human Lacrimal Gland Cells for Potential Clinical Application
Indian Eye Research Group (IERG), 2010, Vol. 1, Pg. 80.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors
Indian Eye Research Group (IERG), 2010, Vol. 1, Pg. 110-111.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors
Shifting Paradigms in Head and Neck Oncology (IFHNOS), 2010, Vol. 1, Pg. 233.
Orbital Retinoblastoma: Present Status and Future Challenges – A Review
Saudi Journal of Ophthalmology, 2010, Vol. 25(2), Pg. 159-167.
Largest Series of Orbital Schwannoma: Clinical Manifestations and Outcomes (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 131.
Genotype-Phenotype and Clinical Correlation in Retinoblastoma (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 129.
RBI Gene Mutations in Retinoblastoma and its Clinical Correlation
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 119-123.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcomes in Ocular Tumors (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 121.
Atypical Presentation of Ciliary Body Medulloepithelioma (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 116.
Histopathology of Retinoblastoma After Primary Chemotherapy (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 100.
Evisceration in Unsuspected Intraocular Tumors
Archives of Ophthalmology, March 2010, Vol. 128(3), Pg. 372-379.
Histopathologic Changes in Uveal Melanoma after Ruthenium 106 Brachytherapy
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S98.
Cultivation and Characterization of Lacrimal and Salivary Gland Cells for Potential Clinical Application
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S98.
Role of HPV, Cell Cycle Markers, and Epigenetic Modifications at DNMT3L Region in Ocular Surface Squamous Neoplasia
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S97.
HPV for Cervical Cancer Screening: Is the Era of the Molecular Pap Smear Upon Us?
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S97.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S88.
Cervical Cancer Screening: Role of Serotyping of HPV as a Bridge of Cytopathology and Molecular Typing?
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S75.
Genotype and Phenotype Correlation Analysis in Retinoblastoma
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S75.
Sebaceous Carcinoma of the Eyelid Metastasizing to the Lacrimal Sac After 5 Years
Orbit (Amsterdam, Netherlands), October 2009, Vol. 28(5), Pg. 309-312.
Histopathology of Retinoblastoma After Primary Chemotherapy
Proceedings of

Dr P Vijay Anand Reddy

Radiation Oncologist

30+ Years Experience

MBBS MD (Radiotherapy) DNB (Radiotherapy) Medical Oncology (ESMO) FUICC FNDM FUICC

English, Hindi, Telugu, Hindi, Telugu

MON-SAT

Overview
Doctor Awards

Overview

Registration No: 10495

Education

Full Member of American Society of Clinical Oncology (ASCO)
Full Member of American Society for Radiation Oncology (ASTRO)
Permanent Member of European Society of Medical Oncology (ESMO)
Permanent Member of Union for International Cancer Control, UICC, Geneva President of Association of Radiation Oncologists of India (AROI)
President of Association of Radiation Oncologists of India (AROI),
Telangana Chapter President of Association of Radiation Oncologists of India (AROI),
AP Chapter (Past)Member of Indian College of Radiation Oncology (ICRO)Chairman, Indian College of Radiation Oncology (ICRO),
INDIA Member of Indian Society of Oncology (ISO)Member of Civil Assistant Surgeon& s Association, Andhra Pradesh Member of Indian Medical Association (IMA)
Member of Indian Co-operative Oncology Network (ICON)Member of Indian Brachytherapy Society (IBS)

Experience

Director & Sr. Consultant, Apollo Cancer Hospital, Hyderabad, since April 2002.
Consultant Ocular Oncologist, L. V. Prasad Eye Institute since 1998.
Stereotactic Radiosurgery Fellowship at Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany, March 2010.
Ocular Oncology Fellowship at Children’s Hospital of Philadelphia, USA & Will’s Eye Hospital, Philadelphia, USA, May-June 2003.
Head & Neck Oncology Fellowship: Peter MacCallum Cancer Institute, Melbourne, Australia, July-August 1998.
Head & Neck Brachytherapy Observership: The Memorial Sloan Kettering Cancer Centre, New York, June 1995.
Nargis Dutt Memorial Cancer Foundation Fellowship: The New York Hospital, Medical Centre of Queens, New York, May-July 1995.
Clinical Observership: Christie Hospital, Manchester, United Kingdom, Sept 1992.
Clinical Oncology Fellowship: The Meyerstein Institute of Oncology, The Middle Sex Hospital, London, July-Sept 1992.
Associate Professor of Radiation Oncology, Kakatiya Medical College, Warangal, April 1999-April 2001.
Assistant Professor, MNJ Institute of Oncology, Red Hills, Hyderabad, April 1992-1999.
Clinical Oncology Fellowship: Adyar Cancer Institute, Chennai, Jan 1990.
Medical Oncology Fellowship: Nizam Institute of Medical Sciences, Hyderabad, Sept 1990.
Radiation Oncology Fellowship: Tata Memorial Hospital, Mumbai, March-August 1990.
Elected as the Chairman ICRO (Indian College of Radiation Oncology), a prestigious body, December 2012.

Doctor Awards

Dr P Vijay Anand Reddy

Dr. Vijay Anand Reddy has been awarded as &ldquo
The Legend in the Field of Oncology&rdquo at the Times Healthcare Achievers Awards function at HICC, Hyderabad on 28th Feb& 2017.
Best Scientific Paper Award 2015&rdquo for Prospective study of Neurocognitive function, performance status, quality of life and local control in patients with 1-3 newly diagnosed brain metastases treated with stereotactic radio surgery alone Awarded by AROICON 2015, Lucknow, INDIA
Best Scientific Paper Award 2014&rdquo for A Prospective Observational Feasibility Study of Hypofractionated Radiotherapy for Clinically localized Carcinoma Prostate Awarded by AROICON 2014, Imphal, INDIA
American Academy of Ophthalmology Achievement Award Best Scientific Paper Award 2009&rdquo for Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors Awarded by AROICON 2009, Hyderabad, INDIA&ldquo
Best Scientific Poster Award 2009&rdquo for Histopathology of Retinoblastoma after primary Chemotherapy Awarded by AROICON 2009, Hyderabad,
INDIA&ldquo BEST POSTER&rdquo AWARD 2008 Awarded by American Academy of Ophthalmology at Atlanta, GA, USA&ldquo
YOUNG INVESTIGATORS AWARD&rdquo 2001 Awarded at New Delhi by Eli Lilly & Company, USA&ldquo INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1998 by UICC, Geneva, Switzerland&ldquo
YOUNG SCIENTIST AWARD&rdquo 1996 Awarded by Indo-American Cancer Congress, New York, USA&ldquo
BEST SCIENTIFIC PAPER AWARD&rdquo 1996 at XVIII National Conference of Assoc.
Oncologists of India&rdquo at Aurangabad&ldquo
NARGIS DUTT MEMORIAL FOUNDATION AWARD&rdquo 1995 Awarded by Nargis Dutt Memorial Foundation, Flushing, New York&ldquo
INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1992 by UICC, Geneva, Switzerland.
Presentations of Cancer: Invited as a Panelist for the &ldquo Gynecological Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017.
Invited as a Panelist for the &ldquo Lung Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017. Invited as a Chairperson for the Panel discussion on &ldquo Opening the Lid for Bevacizumab in Gynecological Malignancies&rdquo CME Organized by Intas Oncology, Hyderabad on July 12, 2017.
Invited as a Chairperson for the Session on &ldquo Expert talk in NSCLC&rdquo CME Organized by Novartis Oncology, Hyderabad on June 13, 2017. &ldquo Radiotherapy in Retinoblastoma&rdquo at Retinoblastoma Networking Workshop, LVPEI,
Hyderabad from June 10-12, 2017. &ldquo Breast&rdquo at Best of ASTRO 2017,
Vizag on May 13-14, 2017. &ldquo Bilateral Breast using TomoTherapy&rdquo at Accuray User& s Meeting,
Bangalore on April 22-23, 2017. &ldquo Re-irradiation When and how to?&rdquo Session on &ldquo
Novel therapies Part III Molecular Neuro-Oncology Resistance and re-treatment&rdquo at 9th annual Conference of Indian Society of Neuro-Oncology (ISNOCON 2017), Bangalore from January 10-12, 2017. &ldquo Crossfire: Surgery vs Radiotherapy for high risk early Prostate Cancer&rdquo at First Prostate Cancer Symposium PRiSM 2016 organized by Dr. Reddy& s Laboratories Ltd. ,
Hyderabad from December 17-18, 2016. &ldquo Optimal treatment for oligo brain metastasis: Role of SRS&rdquo Session on &ldquo CNS Debate (Debator – 1 in favour of SRS)&rdquo at 39th AROICON 2016,
Bhubaneshwar from November 24-27, 2016. &ldquo Plaque Brachytherapy for Ocular Tumor&rdquo Session on &ldquo Paediatrics Oncology&rdquo at 39th AROICON 2016, Bhubaneshwar from November 24-27, 2016. &ldquo Ocular Brachytherapy&rdquo at AROICON – 2016, TN-PY Chapter,
Chennai on October 15-16, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Recent Advances in Surgical Procedures,
Dubai UAE on September 30, 2016. &ldquo Organ Preservation Protocols our experience&rdquo at FHNO South-East Zonal CME on Ca. Larynx, Organized by Apollo Cancer Institute in association with AOI Hyderabad & Telangana State Branches, Hyderabad on September 3, 2016. &ldquo Brachytherapy in Ophthalmic
Tumors&rdquo at 6th Annual Conference of IBSCON 2016, Hyatt Regency, Chennai on August 27-28, 2016. &ldquo Radiotherapy in Elderly Breast Cancer&rdquo Session on &ldquo Breast Cancer in Elderly: Coming of Age&rdquo at Navigating Clinical Conundrums in Breast Cancer, Mumbai on August 20-21, 2016.
&ldquo Overall Scenario of Cancer in India & Prevention & Cure&rdquo Session on &ldquo Cancer Prevention & A Healthy Lifestyle&rdquo at CII Young Indians, Hyderabad on July 28, 2016.
Invited as a Perspective for &ldquo Hard Talk – Perspective in adopting new data&rdquo Session on &ldquo Irradiating the axilla- Why exchange one toxicity for another especially when prognostication is at stake?&rdquo at Controversies in Clinical Oncology, TMH,
Kolkata from July 22-24, 2016. &ldquo New Technology Does it have an impact in the management of Gynaec Cancers Cost vs benefit&rdquo at CME on &ldquo Oncology and Robotics in Gynecology&rdquo , organized by OGSH in association with Apollo Hospitals, Hyderabad on July 16, 2016.
Invited as a Panelist for the Panel discussion on &ldquo Case Based Discussion in Rare Solid Tumors&rdquo at 3rd Mid Term National Conference of Pediatric Hematology Oncology, Hyderabad on July 9-10, 2016.
&ldquo Role of Radiation Oncologist in the Management of Ophthalmic Tumors&rdquo , at EYE CANcer 2016, LVPEI, Hyderabad on July 9, 2016.
Moderator for the Panel Discussion on &ldquo Lung Cancer Non-small Cell / Small Cell / Other&rdquo at Best of ASCO 2016, HICC, Hyderabad on July 1-3, 2016.
Moderator for the Session on &ldquo Each Expert Group Propose Recommendations&rdquo at CME on &ldquo Consensus Recommendations of Expert Group for Management of Advanced Cervical Cancer in India&rdquo , organized by Roche Oncology, Hyderabad on June 18, 2016. &ldquo Cancer Management A Paradigm Shift&rdquo , CME Program on Post Thrombotic Syndrome and Varicose Vein Ulcer Management organized by Apollo Hospitals, Hyderabad in association with IMA, East at Hyderabad on April 24, 2016.
Moderator for the Panel Discussion &ldquo Decision Making for Adjuvant Radiation&rdquo Session on &ldquo Breast Cancer 1: Early Breast Cancer&rdquo at 12th International Conference of Asian Clinical Oncology Society (ACOS), New Delhi from April 8-10, 2016.
Invited as a Chairperson for &ldquo Direction of Current Neuro-oncology Research&rdquo at ISNOCON 2016, Hyderabad from April 1-3, 2016.
Invited as a Panelist for the Head and Neck Cancer& Session on &ldquo Therapeutic Decision Making in Borderline and locally advanced HNSCC&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016.
Invited as a Panelist for the Lunch Symposium on &ldquo Challenges in delivery of chemoradiation in Lung Cancer&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016. &ldquo Did the higher accuracy in treatment delivery translate into noticeable Clinical Improvements?&rdquo at AROI West Bengal Annual State Conference,
Kolkata on February 20-21, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Indian Medical Association (IMA) CME, Hyderabad on February 13, 2016. Invited as a Panelist for the Panel Discussion on &ldquo Nanotechnology based Paclitaxel in Clinical Practice&rdquo at SUN Oncology BEVETEX Symposium, Hyderabad on January 2, 2016.

Research

Research

Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-year Retrospective Study
Translational Vision Science & Technology, June 2017, Vol. 6 No. 3, Article 19, Pg. 1-9.
Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies using Whole Body Nuclear Scintigraphy and SPECT-CT
The American Society of Ophthalmic Plastic and Reconstructive Surgery, 2014, Vol. XX No. XX, Pg. 1-4.
Ophthalmologic Pathology: SY20-2 What is your Diagnosis?
Royal College of Pathologists of Australia, Taylor & Francis, October 2014, Vol. 46 (2), Pg. S30.
Orbital Alveolar Soft-Part Sarcoma: Clinico-pathological Profiles, Management, and Outcomes
Journal of Cancer Research and Therapeutics, April-June 2014, Vol. 10 Issue 2, Pg. 294-298.
Management and Outcome of Retinoblastoma with Vitreous Seeds
American Academy of Ophthalmology, Feb 2014, Vol. 121 (2), Pg. 517-524.
Lacrimal Surgery: Glorious Past, Exciting Present Era, and the Audacity of Hope for a Brilliant Future
Saudi Journal of Ophthalmology, 2014, Vol. 28, Pg. 1-2.
Distant Metastatic Retinoblastoma Without Central Nervous System Involvement
Indian Journal of Ophthalmology, July 2013, Vol. 61(7), Pg. 357-359.
Primary Intraocular Malignant Extrarenal Rhabdoid Tumor: A Clinicopathological Correlation
Journal of Pediatric Ophthalmology and Strabismus, April 2013, Vol. 50, Pg. e18-20.
Adenoid Cystic Carcinoma of the Lacrimal Gland: Role of Nuclear Survivin (BIRC5) as a Prognostic Marker
Histopathology, May 2013, Vol. 62(6), Pg. 840-846.
Optic Nerve Meningeal Hemangiopericytoma: A Clinicopathological Case Report
Survey of Ophthalmology, January 2013, PubMed ID 23294915.
Radiation Oncology in the 21st Century: Changing the Paradigms
Apollo Medicine, June 2012, Vol. 9 No. 2, Pg. 115-125.
Orbital Plasmablastic Lymphoma: A Clinico-Pathological Correlation of a Rare Disease and Review of Literature
Clinical Ophthalmology (Auckland, N.Z.), 2012, Pg. 2049-2057.
Evaluation of HER-2/neu Status in Breast Cancer Specimens using Immunohistochemistry (IHC) & Fluorescence in-situ Hybridization (FISH) Assay
Indian Journal of Medical Research, March 2012, Pg. 312-317.
Establishing Human Lacrimal Gland Cultures with Secretory Function
PLoS One, 2012, Vol. 7(1), e29458.
High Dose Rate Interstitial Brachytherapy in Carcinoma Eyelid: Can it be a Primary Treatment Modality?
Journal of Cancer Research and Therapeutics, Oct-Dec 2011, Vol. 7(4), Pg. 498-499.
First Indian Experience with Shaped Beam Radiosurgery of Cranial and Spinal Lesions on Novalis-Tx Linear Accelerator with ExacTrac 6D Robotic Couch
10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011, Pg. 1166.
Set-up Accuracy with Frameless Radiosurgery of Intracranial Lesions using ExacTrac 6-D Robotic Couch on Novalis-Tx Linear Accelerator
10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011, Pg. 1147.
Comparison of Intensity Modulated Stereotactic Radiosurgery with Conventional Stereotactic Conformal Beam Radiosurgery in Vestibular Schwannomas
10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011, Pg. 1003.
The New Radiation Technology and Techniques: Does it Matter in Gynec Cancer?
Annals of IMA Academy of Medical Specialities, 2011, Pg. 49-53.
Evaluation of Human Lacrimal Gland Cultures for Secretory Function and Putative Stem Cells
Indian Eye Research Group (IEGR), 2011, Pg. 84.
Orbital Retinoblastoma: Where Do We Go from Here?
Journal of Cancer Research and Therapeutics, May 2011, Vol. 7(1), Pg. 11-14.
Cultivation and Characterization of Human Lacrimal Gland Cells for Potential Clinical Application
Indian Eye Research Group (IERG), 2010, Vol. 1, Pg. 80.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors
Indian Eye Research Group (IERG), 2010, Vol. 1, Pg. 110-111.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors
Shifting Paradigms in Head and Neck Oncology (IFHNOS), 2010, Vol. 1, Pg. 233.
Orbital Retinoblastoma: Present Status and Future Challenges – A Review
Saudi Journal of Ophthalmology, 2010, Vol. 25(2), Pg. 159-167.
Largest Series of Orbital Schwannoma: Clinical Manifestations and Outcomes (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 131.
Genotype-Phenotype and Clinical Correlation in Retinoblastoma (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 129.
RBI Gene Mutations in Retinoblastoma and its Clinical Correlation
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 119-123.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcomes in Ocular Tumors (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 121.
Atypical Presentation of Ciliary Body Medulloepithelioma (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 116.
Histopathology of Retinoblastoma After Primary Chemotherapy (Abs)
Saudi Journal of Ophthalmology, 2010, Vol. 24, Pg. 100.
Evisceration in Unsuspected Intraocular Tumors
Archives of Ophthalmology, March 2010, Vol. 128(3), Pg. 372-379.
Histopathologic Changes in Uveal Melanoma after Ruthenium 106 Brachytherapy
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S98.
Cultivation and Characterization of Lacrimal and Salivary Gland Cells for Potential Clinical Application
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S98.
Role of HPV, Cell Cycle Markers, and Epigenetic Modifications at DNMT3L Region in Ocular Surface Squamous Neoplasia
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S97.
HPV for Cervical Cancer Screening: Is the Era of the Molecular Pap Smear Upon Us?
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S97.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S88.
Cervical Cancer Screening: Role of Serotyping of HPV as a Bridge of Cytopathology and Molecular Typing?
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S75.
Genotype and Phenotype Correlation Analysis in Retinoblastoma
Journal of Cancer Research and Therapeutics, 2009, Vol. 5(2), Pg. S75.
Sebaceous Carcinoma of the Eyelid Metastasizing to the Lacrimal Sac After 5 Years
Orbit (Amsterdam, Netherlands), October 2009, Vol. 28(5), Pg. 309-312.
Histopathology of Retinoblastoma After Primary Chemotherapy
Proceedings of

Dr P Vijay Anand Reddy

Overview

Education

Experience

Doctor Awards

Research

Dr P Vijay Anand Reddy

Overview

Education

Experience

Doctor Awards

Dr P Vijay Anand Reddy

Research

Top Hospitals

Emergency

Apollo Lifeline International

Health Help Line

Request A Call Back

Request A Call Back